This PVH Analyst Turns Bearish; Here Are Top 3 Downgrades For Thursday

PVH Corp.
Apollo Commercial Real Estate Finance, Inc.
Tonix Pharmaceuticals Holding Corp.
Castle Biosciences
Boost Run Inc. Class A

PVH Corp.

PVH

0.00

Apollo Commercial Real Estate Finance, Inc.

ARI

0.00

Tonix Pharmaceuticals Holding Corp.

TNXP

0.00

Castle Biosciences

CSTL

0.00

Boost Run Inc. Class A

BRUN

0.00

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • B of A Securities analyst Heather Balsky downgraded PVH Corp (NYSE:PVH) from Neutral to Underperform and lowered the price target from $90 to $70. PVH shares closed at $72.71 on Wednesday. See how other analysts view this stock.
  • BTIG analyst Thomas Catherwood downgraded Apollo Commercial Real Estate Finance Inc (NYSE:ARI) from Buy to Neutral. ARI shares closed at $10.75 on Wednesday. See how other analysts view this stock.
  • Truist Securities analyst Gregory Renza downgraded Exelixis, Inc. (NASDAQ:EXEL) from Buy to Hold and raised the price target from $51 to $54. Exelixis shares closed at $52.87 on Wednesday. See how other analysts view this stock.

Considering buying PVH stock? Here’s what analysts think:

Photo via Shutterstock

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.